You just read:

Immune Pharmaceuticals Enters a Research Partnership to Develop Mono- and Bispecific Antibodies Against Novel Targets in the Tumor Microenvironment

News provided by

Immune Pharmaceuticals Inc.

Jan 23, 2017, 08:45 ET